Weave price target lowered to $16 from $20 at Stifel

Stifel analyst J. Parker Lane lowered the firm’s price target on Weave (WEAV) to $16 from $20 and keeps a Buy rating on the shares. Shares have underperformed year-to-date, but following this pullback the firm sees a favorable risk/reward scenario into earnings next month as it argues that the company possesses a “relatively inexpensive, efficiency-driving platform” for markets like dental, optometry, veterinary, and specialty medical that should be more insulated from tariff/macro volatility than software peers.